Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.06 - $0.27 $15,421 - $69,398
257,030 New
257,030 $15,000
Q1 2023

May 15, 2023

BUY
$0.46 - $1.2 $4,644 - $12,115
10,096 Added 61.52%
26,508 $12,000
Q4 2022

Feb 14, 2023

BUY
$0.85 - $1.49 $5,145 - $9,020
6,054 Added 58.45%
16,412 $14,000
Q3 2022

Nov 14, 2022

BUY
$0.15 - $3.05 $1,553 - $31,591
10,358 New
10,358 $11,000
Q4 2021

Feb 15, 2022

SELL
$7.29 - $10.49 $197,405 - $284,058
-27,079 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$7.94 - $10.14 $215,007 - $274,581
27,079 New
27,079 $224,000

Others Institutions Holding LMDX

About LumiraDx Ltd


  • Ticker LMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 170,688,000
  • Market Cap $1.71M
  • Description
  • LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The compa...
More about LMDX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.